VEGFC Overexpression in Kidney Progenitor Cells Is a Model of Renal Lymphangiectasia.

IF 7.4 1区 医学 Q1 HEMATOLOGY
Michael D Donnan, Dilip K Deb, Vidhi Dalal, Valentin David, Daniele Procissi, Susan E Quaggin
{"title":"VEGFC Overexpression in Kidney Progenitor Cells Is a Model of Renal Lymphangiectasia.","authors":"Michael D Donnan, Dilip K Deb, Vidhi Dalal, Valentin David, Daniele Procissi, Susan E Quaggin","doi":"10.1161/ATVBAHA.124.319743","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Lymphangiogenesis is believed to be a protective response in the setting of multiple forms of kidney injury and mitigates the progression of interstitial fibrosis. To augment this protective response, promoting kidney lymphangiogenesis is being investigated as a potential treatment to slow the progression of kidney disease. As injury-related lymphangiogenesis is driven by signaling from the receptor VEGFR3 (vascular endothelial growth factor receptor 3) in response to the cognate growth factor VEGF (vascular endothelial growth factor)-C released by tubular epithelial cells, this signaling pathway is a candidate for future kidney therapeutics. However, the consequences to kidney development and function to targeting this signaling pathway remain poorly defined.</p><p><strong>Methods: </strong>We generated a new mouse model expressing <i>Vegfc</i> under regulation of the nephron progenitor Six2Cre driver strain (<i>Six2Vegfc</i>). Mice underwent a detailed phenotypic evaluation. Whole kidneys were processed for histology and 3-dimensional imaging.</p><p><strong>Results: </strong><i>Six2Vegfc</i> mice had reduced body weight and kidney function compared with littermate controls. <i>Six2Vegfc</i> kidneys demonstrated large peripelvic fluid-filled lesions with distortion of the pelvicalcyceal system which progressed in severity with age. Three-dimensional imaging showed a 3-fold increase in total cortical vascular density. Histology confirmed a substantial increase in LYVE1+ (lymphatic vessel endothelial hyaluronan receptor-1)/PDPN+ (podoplanin)/VEGFR3+ lymphatic capillaries extending alongside EMCN+ (endomucin) peritubular capillaries. There was no change in EMCN+ peritubular capillary density.</p><p><strong>Conclusions: </strong>Kidney lymphatic density was robustly increased in the <i>Six2Vegfc</i> mice. There were no changes in peritubular blood capillary density despite these endothelial cells also expressing VEGFR3. The model resulted in malformation of the lymphatic hilar plexus, resulting in severe hydronephrosis that resembled a human condition termed renal lymphangiectasia. This study defines the vascular consequences of augmenting VEGFC signaling during kidney development and provides new insight into human renal lymphatic malformations.</p>","PeriodicalId":8401,"journal":{"name":"Arteriosclerosis, Thrombosis, and Vascular Biology","volume":" ","pages":""},"PeriodicalIF":7.4000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arteriosclerosis, Thrombosis, and Vascular Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/ATVBAHA.124.319743","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Lymphangiogenesis is believed to be a protective response in the setting of multiple forms of kidney injury and mitigates the progression of interstitial fibrosis. To augment this protective response, promoting kidney lymphangiogenesis is being investigated as a potential treatment to slow the progression of kidney disease. As injury-related lymphangiogenesis is driven by signaling from the receptor VEGFR3 (vascular endothelial growth factor receptor 3) in response to the cognate growth factor VEGF (vascular endothelial growth factor)-C released by tubular epithelial cells, this signaling pathway is a candidate for future kidney therapeutics. However, the consequences to kidney development and function to targeting this signaling pathway remain poorly defined.

Methods: We generated a new mouse model expressing Vegfc under regulation of the nephron progenitor Six2Cre driver strain (Six2Vegfc). Mice underwent a detailed phenotypic evaluation. Whole kidneys were processed for histology and 3-dimensional imaging.

Results: Six2Vegfc mice had reduced body weight and kidney function compared with littermate controls. Six2Vegfc kidneys demonstrated large peripelvic fluid-filled lesions with distortion of the pelvicalcyceal system which progressed in severity with age. Three-dimensional imaging showed a 3-fold increase in total cortical vascular density. Histology confirmed a substantial increase in LYVE1+ (lymphatic vessel endothelial hyaluronan receptor-1)/PDPN+ (podoplanin)/VEGFR3+ lymphatic capillaries extending alongside EMCN+ (endomucin) peritubular capillaries. There was no change in EMCN+ peritubular capillary density.

Conclusions: Kidney lymphatic density was robustly increased in the Six2Vegfc mice. There were no changes in peritubular blood capillary density despite these endothelial cells also expressing VEGFR3. The model resulted in malformation of the lymphatic hilar plexus, resulting in severe hydronephrosis that resembled a human condition termed renal lymphangiectasia. This study defines the vascular consequences of augmenting VEGFC signaling during kidney development and provides new insight into human renal lymphatic malformations.

肾脏祖细胞中 VEGFC 过度表达是肾淋巴管扩张症的一种模型
背景:淋巴管生成被认为是多种肾脏损伤情况下的一种保护性反应,可减轻间质纤维化的进展。为了增强这种保护性反应,人们正在研究促进肾脏淋巴管生成的潜在疗法,以减缓肾脏疾病的进展。由于与损伤相关的淋巴管生成是由受体 VEGFR3(血管内皮生长因子受体 3)发出的信号驱动的,它是对肾小管上皮细胞释放的同源生长因子 VEGF(血管内皮生长因子)-C 的反应,因此这一信号通路是未来肾脏治疗的候选途径。然而,靶向这一信号通路对肾脏发育和功能的影响尚不明确:方法:我们在肾小球祖细胞Six2Cre驱动株(Six2Vegfc)的调控下生成了一种表达Vegfc的新小鼠模型。小鼠接受了详细的表型评估。对整个肾脏进行组织学和三维成像处理:结果:与同卵对照组相比,Six2Vegfc 小鼠的体重和肾功能都有所下降。6 只 2Vegfc 肾脏表现出较大的肾盂周围积液病变,肾盂膀胱系统扭曲,其严重程度随年龄增长而加剧。三维成像显示,肾皮质总血管密度增加了 3 倍。组织学检查证实,LYVE1+(淋巴管内皮透明质酸受体-1)/PDPN+(podoplanin)/VEGFR3+淋巴毛细血管大量增加,与 EMCN+(内粘蛋白)管周毛细血管一起延伸。EMCN+管周毛细血管密度没有变化:结论:Six2Vegfc 小鼠的肾脏淋巴管密度显著增加。结论:Six2Vegfc 小鼠的肾脏淋巴管密度显著增加,尽管这些内皮细胞也表达 VEGFR3,但肾小管周围毛细血管密度没有变化。该模型导致淋巴环丛畸形,造成严重的肾积水,类似于人类的肾淋巴管扩张症。这项研究确定了在肾脏发育过程中增强 VEGFC 信号的血管后果,并为人类肾脏淋巴畸形提供了新的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.60
自引率
2.30%
发文量
337
审稿时长
2-4 weeks
期刊介绍: The journal "Arteriosclerosis, Thrombosis, and Vascular Biology" (ATVB) is a scientific publication that focuses on the fields of vascular biology, atherosclerosis, and thrombosis. It is a peer-reviewed journal that publishes original research articles, reviews, and other scholarly content related to these areas. The journal is published by the American Heart Association (AHA) and the American Stroke Association (ASA). The journal was published bi-monthly until January 1992, after which it transitioned to a monthly publication schedule. The journal is aimed at a professional audience, including academic cardiologists, vascular biologists, physiologists, pharmacologists and hematologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信